Digital Exclusives
Innovative medical products help wipe away the ugly vision of unnecessary health care.
Health care reform has led drugmakers and hospital systems to carry out more rigorous cost-benefit value analyses. Take the experience of two alumni at BD and Valley Health System.
The promise of big data in providing value to our health care system lies in delivering the right data at the right time to the right person.
Three steps to mobile health care innovations and how developers can provide value.
We asked four Wharton Club Network presidents how they have been so successful driving engagement among their alumni groups.
Value creation in health care is likely to come from innovation. Come and meet some of the people behind the change.
Customer service as part of the health care experience is about to have a lot more value to caregivers as health reform gets under way.
The U.S. is likely to follow the U.K.’s lead in imposing cost discipline to cancer therapy.
For society, medical providers and people receiving cancer care, serious questions remain about the "value" of treatment.
We continue our exploration of the issues surrounding the value of cancer treatment to society and individuals.
Is the arms race in the genetic mapping of cancer worth the investment? Cost-effectiveness analysis could provide our answer.
It’s not just the government’s role to allocate health care resources properly. It is time for all relevant parties to think rationally.
The U.S. federal government has new ways to reduce waste in Medicare and across the health care system.
The medical community’s mindset and financing continue to explain why health care is plagued with inefficient allocation of resources.
The inefficient allocation of resources explains why so many Medicare dollars are squandered. Here’s a simple example to explain how it happens.
Against a backdrop of spiraling health care costs, Wharton’s alumni create and embrace innovative strategies to transform the industry.
